Skip to main content
. 2018 Dec 28;17(2):2400–2408. doi: 10.3892/ol.2018.9871

Figure 4.

Figure 4.

ATAD2 is the direct target of miR-372 in RCC. (A) The putative binding sites of miR-372 in the ATAD2 3′-UTR. (B) The luciferase activities of the ATAD2 3′UTR was detected by luciferase reporter gene assays in RCC cells which were cotransfected with wild-type ATAD2 3′UTR or mutational type ATAD2 3′UTR and miR-372 mimics, respectively. (C) ATAD2 expression in 786-O treated with miR-372 mimics. (D) ATAD2 expression in Caki-1 treated with miR-372 inhibitor. *P<0.05.